Analysis methods for in-beam PET images in proton therapy treatment verification: a comparison based on Monte Carlo simulations. (1st January 2023)

• Record Type: Journal Article
• Authors: Moglioni, M.; Kraan, A.C.; Berti, A.; Carra, P.; Cerello, P.; Ciocca, M.; Ferrero, V.; Fiorina, E.; Mazzoni, E.; Morrocchi, M.; Pennazio, F.; Retico, A.; Rosso, V.; Sportelli, G.; Vitolo, V.; Bisogni, G.
• Is Part Of: Journal of instrumentation. Volume 18:Number 1(2023)
• Publication Date: 2023-01-01
• Subjects: Analysis and statistical methods -- Gamma camera, SPECT, PET PET/CT, coronary CT angiography (CTA) -- Instrumentation for hadron therapy; Scientific apparatus and instruments -- Periodicals; 502.84
• DOI: 10.1088/1748-0221/18/01/C01001
• Languages: English
• ISSNs: 1748-0221

Abstract

Abstract: Background and purpose: in-beam Positron Emission Tomography (PET) is one of the modalities that can be used for in-vivo non-invasive treatment monitoring in proton therapy. PET distributions obtained during various treatment sessions can be compared in order to identify regions that have anatomical changes. The purpose of this work is to test and compare different analysis methods in the context of inter-fractional PET image comparison for proton treatment verification. Methods: for our study we used the FLUKA Monte Carlo code and artificially generated CT scans to simulate in-beam PET distributions at different stages during proton therapy treatment. We compared the Beam-Eye-View method, the Most-Likely-Shift method, the Voxel-Based-Morphology method and the gamma evaluation method to compare PET images at the start of treatment, and after a few weeks of treatment. The results were compared to the CT scan. Results and conclusions: three-dimensional methods like VBM and gamma are preferred above two-dimensional methods like MLS and BEV if much statistics is available, since the these methods allow to identify the regions with anomalous activity. The VBM approach has as disadvantage that a larger number of MC simulations is needed. The gamma analysis has the disadvantage that no clinical indication exist on tolerance criteria. In terms of calculation time, the BEV and MLS method are preferred. We recommend to use the four methods together, in order to best identify the location and cause of the activity changes.